Lubiprostone is a locally acting ClC-2 chloride channel activator that increases fluid secretion into the intestines and is helpful in improving constipation. It is approved for adults by the US Food and Drug Administration but not for children yet.

Prucalopride is a prokinetic agent that facilitates colonic motility and movement. This also improves bowel function and constipation-related symptoms but had only been tested in adults and is not recommended in children at this time.